Medpace Holdings Inc
NASDAQ:MEDP
Medpace Holdings Inc
Operating Income
Medpace Holdings Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medpace Holdings Inc
NASDAQ:MEDP
|
Operating Income
$354.7m
|
CAGR 3-Years
26%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
22%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
31%
|
CAGR 5-Years
21%
|
CAGR 10-Years
15%
|
See Also
What is Medpace Holdings Inc's Operating Income?
Operating Income
354.7m
USD
Based on the financial report for Mar 31, 2024, Medpace Holdings Inc's Operating Income amounts to 354.7m USD.
What is Medpace Holdings Inc's Operating Income growth rate?
Operating Income CAGR 5Y
27%
Over the last year, the Operating Income growth was 18%. The average annual Operating Income growth rates for Medpace Holdings Inc have been 26% over the past three years , 27% over the past five years .